Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.770
+0.075 (2.03%)
Aug 3, 2026, 12:51 PM EDT - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $473.01 million as of August 3, 2026. Its market cap has increased by 24.67% in one year.
Market Cap
473.01M
Enterprise Value
396.45M
1-Year Change
24.67%
Ranking
Category
Stock Price
$3.77
ChartMarket Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $385.20M to $473.01M, an increase of 22.80%. That is a compound annual growth rate of 2.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 473.01M | -39.98% |
| Dec 31, 2025 | 788.10M | 142.79% |
| Dec 31, 2024 | 324.60M | 140.62% |
| Dec 29, 2023 | 134.90M | 176.43% |
| Dec 30, 2022 | 48.80M | -68.76% |
| Dec 31, 2021 | 156.20M | -13.17% |
| Dec 31, 2020 | 179.90M | 23.39% |
| Dec 31, 2019 | 145.80M | -7.19% |
| Dec 31, 2018 | 157.10M | -59.22% |
| Jul 25, 2018 | 385.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 697.26M |
| Ironwood Pharmaceuticals | 696.31M |
| Tilray Brands | 615.69M |
| Kamada | 418.44M |
| BioAge Labs | 401.85M |
| Canopy Growth | 388.19M |
| Evolus | 384.59M |
| Emergent BioSolutions | 372.53M |